[Retracted] Reduced miR ‑202 levels enhanced oral cancer development via targeting Sp1

Exp Ther Med. 2024 Apr 15;27(6):251. doi: 10.3892/etm.2024.12539. eCollection 2024 Jun.ABSTRACT[This retracts the article DOI: 10.3892/etm.2019.7603.].PMID:38682115 | PMC:PMC11046176 | DOI:10.3892/etm.2024.12539
Source: Experimental and Therapeutic Medicine - Category: General Medicine Authors: Source Type: research